Archive - October 2024

New Drug Applications

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma

3 months ago

New Drug Applications

Camurus Provides Regulatory Update on the US NDA for CAM2029 in Acromegaly

3 months ago

Pharma Industry News

Pharmaceutical Sales Customer Engagement – Atlanta East, GA

3 months ago

New Drug Applications

FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent

3 months ago

New Drug Applications

Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

3 months ago

Pharma Industry News

AstraZeneca’s Polyneuropathy Treatment Recommended for EU Approval

3 months ago

Pharma Industry News

AAPS PharmSci 360: LBFs and Tackling Oral Biologic Formulations

3 months ago

Pharma Industry News

Designing a Strategic Roadmap for Seamless Product Development 

3 months ago

Pharma Industry News

CHMP Gives Positive Opinion to Novo Nordisk Hemophilia Treatment

3 months ago

Pharma Industry News

GSK, Cambridge to Partner on R&D for Kidney and Respiratory Diseases

3 months ago